Dronedarone (multaq) is used in adults with past or current occurrence of a heart condition called atrial fibrillation (AF) to prevent the fibrillation coming back or to lower the heart rate.
Following cases of rare but serious liver injury in patients using this drug, a safety warning has been issued from the Irish Medicines Board.
Cases of livery injury, including two cases of liver failure requiring transplantations have been reported in patients receiving dronedarone. Some of these cases occurred early after started treatment.
Since dronedarone was licensed in 2009 there have been reports of liver function test abnormalities. The two case report of liver transplantations occurred at 4.5 and 6 months after initiation of treatment in the patients. In one case the liver injury was not reversible after discontinuation of dronedarone.
What Should I Do If I Have Been Prescribed Dronedarone?
Liver function tests should be immediately performed –
- Prior to treatment,
- On a Monthly basis for 6 months,
- At months 9 and 12 and periodically there after.
Patients should be advised to contact healthcare professionals immediately in case of signs or symptoms of liver injury. If you have been effected by this article please feel free to contact Liam Moloney Solicitor, Naas on 045 898000 or log onto www.moloneysolicitors.ie for further information in relation to your rights.